Mucoangin®
www.mucoangin.com
The throat is quite a small area but it’s very important – and very sensitive. That’s why even a mild sore throat can be such an uncomfortable interruption to enjoying your daily life.
Pain in sore throat is the hallmark of acute pharyngitis, which is usually caused by a viral infection. The infection is self-limited and recovery is normally within a couple of days. What is most troubling is the continuous pain in the throat, which is worst when swallowing. The pain impacts many activities of daily life and the main goal of the treatment is thus to reduce pain.
Mucoangin® contains ambroxol, an efficacious and well-tolerated local anesthetic which relieves sore throat pain by blocking the pain receptors in the throat.
State-of-the-art clinical studies have demonstrated the efficacy of Mucoangin® in relieving pain in acute sore throat, with a fast onset of action and duration of effect of at least 3 hours.
Beside its local anesthetic effect, ambroxol also has anti-inflammatory properties. This anti-inflammatory effect has been shown in vitro to inhibit the release of pro-inflammatory mediators. It has also been proven in patients treated with Mucoangin®, through the reduction of the pharyngeal (throat) redness associated with sore throat.
Mucoangin® can be found in two different pharmaceutical forms: Lozenges and Spray. Both formulations are sold under three different brand names worldwide: Mucoangin®, Lysopaïne® Ambroxol, and Lizipadol®. All contain ambroxol. Commercialization of Lysopaïne® and Lizipadol® brands is limited to certain countries.
Read the patient information leaflet carefully. If you have any questions, ask your doctor or pharmacist.
Local Websites
Austria | Denmark | Germany | Spain |
Sweden | Venezuela |